Update - Zayed National Museum and Bahrain Launch Six-Week Archaeologica… Transport - Dubai RTA Introduces Five-Star Rating System for Taxi Companies… Weather - Rain Expected in Some Areas on November 16 as Temperatures Drop…

Send an Inquiry

Fill in the details below and our team will get back to you.

Healthcare 1 min read 88 views

Sanofis advanced diabetes therapy, Toujeo, approved by Kuwait Ministry of Health

The control of blood sugar level levels in patients with diabetes stays sub-optimal, with 1 in 2 patients on treatment for diabetes not reaching their glycemic objectives. With the aim of resolving this unmet requirement of patients, Sanofi, under the patronage of Kuwait Diabetes Society, introduced Toujeo (insulin glargine U300), a next generation basal insulin, to enhance the control of blood sugar in adults living with type 1 and type 2 diabetes.
In alignment with the on-going efforts in Kuwait to improve diabetes management, the introduction of Toujeo will assist enhance treatment outcome and provide much better treatment alternatives for some people with diabetes.

"With the rising occurrence of diabetes in the nation, our venture is to embrace every measure towards making sure reliable diabetes control for our clients. The launch of the brand-new therapy is a favorable addition to our existing diabetes treatment portfolio. Together with Sanofi, we are pleased to be the very first country in the Middle East making this offered to our clients," said Dr. Hessa Al Kandari, President of Kuwait Diabetes Society.
Talking about the challenges faced by patients, Dr. Waleed Al-Dahi, Consultant Endocrinologist & Diabetes, Mubarak Al-Kabeer Hospital, stated, "Hypoglycemia is one of the crucial worrying adverse effects for people with diabetes. It triggers patients to decrease their insulin doses, resulting in irregular blood sugar level levels. In addition, the concern over hypoglycemia causes clients to eat at differing hours and in larger quantities causing weight gain.".

Toujeo offers stable control that lasts a complete 24 hours and beyond, v.It likewise provides the benefits of dosage flexibility (up to 3 hours) when needed and deals with the issue of insulin-related body weight gain. The new therapy has a neutral impact on cardiovascular conditions, making sure long-lasting safety for clients with co-morbidities v, vi.

"Sanofi is proud of its leadership and long heritage in diabetes and insulin therapies, consisting of Lantus which has supported patients in the management of their diabetes for more than a years. We are committed to bringing innovative therapies that intend to provide much better health results for individuals with diabetes in Kuwait. With the introduction of Toujeo , we provide reliable option that will resolve some of the previously unmet needs of diabetes clients in the country," stated Jean-Paul Scheuer, Country Chair and General Manager, Rx for Sanofi Gulf.

Toujeo has received approval from a lot of international health authorities, consisting of the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) vii, in addition to the Kuwait Ministry of Health. The approvals were based upon a series of medical trials (EDITION) that were conducted on over 3500 clients, and which results proved positive and effective .

Related News

More on Healthcare

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Business

Big 5 Global 2026: Six French companies to showcase advanced construction technologies in Dubai

Six French companies will present their construction technologies and expertise at Big 5 Global 2026, scheduled to take place from November 23 to 26 at the Dubai World Trade Centre. Supported by Business France, AITENDERS, ALPHI ME, ARIADIS, COMUS, CSTB and QUADRA will showcase solutions across...

Nov 16, 2026 · 3 min
Education

JICE connects UAE students with higher education opportunities in Japan at NAJAH Abu Dhabi 2026

The Japan International Cooperation Center (JICE) welcomed approximately 1,200 visitors to the Japan Pavilion at NAJAH Abu Dhabi 2026, held from October 18 to 21 at ADNEC Centre Abu Dhabi. The initiative introduced students and families to higher education opportunities in Japan through...

Nov 16, 2026 · 2 min
Real Estate

Emirates REIT reports 12% rise in property income as Funds from Operations nearly double in Q3 2026

Emirates REIT (CEIC) PLC reported strong financial results for the nine months ended September 30, 2026, with year-on-year growth in property income, operating profit and Funds from Operations (FFO), alongside improvements in its balance sheet. Equitativa (Dubai) Limited, the manager of Emirates...

Nov 16, 2026 · 2 min
Education

Almasar Alshamil Education outlines vision for future of learning at Education Investment MENA 2026

Almasar Alshamil Education Chief Executive Officer Majed Al Mutairi joined regional education leaders at Education Investment MENA 2026 in Dubai, where discussions focused on the future of learning, the role of technology and the importance of collaboration across the education sector. Held on...

Nov 16, 2026 · 2 min
Trusted by

Our Associates

Brands and organisations that work with Day of Dubai.